BNTC compared with MOLN: revenue, margins and what each company keeps, and the suppliers and customers both name

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

MOLNMolecular Partners AG

Mkt capRevenueRevenue

Compare

BNTCBenitec Biopharma Inc.

MOLNMolecular Partners AG

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BNTC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 15 '26±33.9%▼−8.53%×0.25

Q3 FY26±46.8%▲+1.72%×0.04

Feb 12 '26±42.4%▼−2.66%×0.06

Nov 17 '25±33.2%▲+2.81%×0.08

MOLN1 of 4 reports

Reportimpliedrealized× implied

Oct 29 '26—▼−4.88%—

= impliedBNTC realized, solidMOLN realized, hatchedOne scale, both sides: full bar = 47%× = |realized| ÷ impliedSource: market data

BNTCBenitec Biopharma Inc.

8.77▲+0.35%· post 8.49· delayed

Mkt cap$304.9MRevenue$7,000Q4 FY23

MOLNMolecular Partners AG

3.98▲+11.17%· post 3.40

After hoursNov 2 '26

Mkt cap$144.5MRevenue—

Compare

After hoursNov 2 '26

BNTCBenitec Biopharma Inc.

MOLNMolecular Partners AG

8.77▲+0.35%post 8.49delayed

Price

3.98▲+11.17%post 3.40

$304.9M

Mkt cap

$144.5M

Q4 FY23$7,000

Revenue

—

BNTC8.77▲+0.35%vsMOLN3.98▲+11.17%After hoursNov 2 '26